Reset the Clock on Schizophrenia: SPG302, A Regenerative Treatment
Behind the Steering Wheel of Your Brain: Residual Negative and Cognitive Symptoms in Schizophrenia
Phase 2 Trial Open Enrollment for SPG302, First Synaptic Regenerative Approach to Treat Schizophrenia
SPG302: A Synaptic Regenerative Treatment Option for Schizophrenia
First Synaptic Regenerative Therapy for Schizophrenia Under Investigation
Synapse-restoring pill set for human trials as novel schizophrenia treatment
